Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$0.26 - $0.61 $175,674 - $412,158
-675,670 Reduced 74.97%
225,538 $60,000
Q2 2023

Aug 14, 2023

BUY
$0.46 - $0.81 $69,647 - $122,640
151,408 Added 20.19%
901,208 $450,000
Q1 2023

May 12, 2023

SELL
$0.36 - $1.0 $78,564 - $218,236
-218,236 Reduced 22.54%
749,800 $494,000
Q4 2022

Feb 13, 2023

SELL
$0.29 - $0.47 $9,605 - $15,567
-33,122 Reduced 3.31%
968,036 $336,000
Q3 2022

Nov 14, 2022

BUY
$0.38 - $0.73 $239,176 - $459,470
629,411 Added 169.31%
1,001,158 $449,000
Q2 2022

Aug 09, 2022

BUY
$0.37 - $0.61 $55,895 - $92,151
151,068 Added 68.46%
371,747 $148,000
Q1 2022

May 11, 2022

BUY
$0.53 - $1.19 $116,959 - $262,608
220,679 New
220,679 $138,000

Others Institutions Holding ASXC

About ASENSUS SURGICAL, INC.


  • Ticker ASXC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 236,719,008
  • Market Cap $82.9M
  • Description
  • Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...
More about ASXC
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.